Evidence map›Paper›PMID 38342618›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Light Color-Controlled pH-Adjustment of Aqueous Solutions Using Engineered Proteoliposomes.

Daniel Harder, Noah Ritzmann, Zöhre Ucurum, Daniel J Müller, Dimitrios Fotiadis

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Light Color-Controlled pH-Adjustment of Aqueous Solutions Using Engineered Proteoliposomes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daniel HarderInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, 3012, Switzerland.
Noah RitzmannNational Centre of Competence in Research (NCCR), Molecular Systems Engineering, Basel, Switzerland.
Zöhre UcurumInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, 3012, Switzerland.
Daniel J MüllerNational Centre of Competence in Research (NCCR), Molecular Systems Engineering, Basel, Switzerland.
Dimitrios FotiadisInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, 3012, Switzerland.ORCID 0000-0001-9682-7931
University of Bern · CHETH Zurich · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung NCCR Molecular Systems EngineeringUniversity of Bern
6 · The paper itself

Abstract

Controlling the pH at the microliter scale can be useful for applications in research, medicine, and industry, and therefore represents a valuable application for synthetic biology and microfluidics. The presented vesicular system translates light of different colors into specific pH changes in the surrounding solution. It works with the two light-driven proton pumps bacteriorhodopsin and blue light-absorbing proteorhodopsin Med12, that are oriented in opposite directions in the lipid membrane. A computer-controlled measuring device implements a feedback loop for automatic adjustment and maintenance of a selected pH value. A pH range spanning more than two units can be established, providing fine temporal and pH resolution. As an application example, a pH-sensitive enzyme reaction is presented where the light color controls the reaction progress. In summary, light color-controlled pH-adjustment using engineered proteoliposomes opens new possibilities to control processes at the microliter scale in different contexts, such as in synthetic biology applications.

Indexed as

BacteriorhodopsinsHydrogen-Ion ConcentrationProteolipidsBacteriorhodopsinsProteolipidsproteoliposomesbacteriorhodopsinlight‐driven proton pumpproteoliposomeproteorhodopsinsynthetic biology

Identifiers

PMID38342618
PMCPMC11022694
OpenAlexW4392730245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.